NCT01308567 2019-06-05
FIRSTANA
Sanofi
Phase 3 Completed
Clinical Trials
14 trialsNCT01718353 2017-11-20
TAXYNERGY
Sanofi
Phase 2 Completed
NCT01308580 2017-04-17
PROSELICA
Sanofi
Phase 3 Completed
NCT01751308 2016-08-12
Safety and Efficacy of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors
Sanofi
Phase 1/2 Completed
NCT01649635 2016-07-06
PROSPECTA
Sanofi
Phase 4 Completed
NCT01140607 2015-07-21
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
Sanofi
Phase 1 Completed
NCT01500720 2015-04-13
Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer
Sanofi
Phase 2 Completed
NCT01324583 2015-01-07
Dose Escalation Study With Cabazitaxel in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate Cancer
Sanofi
Phase 1 Completed
NCT01576029 2013-12-24
SWITCH
Sanofi
Phase 2 Completed
NCT01001221 2013-09-11
Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid Tumor
Sanofi
Phase 1/2 Terminated
NCT00925743 2013-05-16
A Study to Evaluate the Effects of Combining Cabazitaxel With Cisplatin Given Every 3 Weeks in Patients With Advanced Solid Cancer
Sanofi
Phase 1 Completed
NCT01755390 2012-12-24
A Dose Finding Study of XRP6258 in Patients With Advanced Solid Tumors
Sanofi
Phase 1 Completed
NCT01087021 2011-12-16
QT-Cab
Sanofi
Phase 1 Completed
NCT00417079 2011-03-10
TROPIC
Sanofi
Phase 3 Completed